Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 42708-172

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 42708-172). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (42708 172 20 Rev 1)

Label (42708 172 20   Rev 1)
Label for Cyclobenzaprine Hydrochloride Tablets USP, 5 mg, containing 20 film-coated tablets. The label includes dosage instructions with blanks for number of tablets, frequency, and duration. Distributed by QPharma Inc, Cedar Knolls, NJ. It is marked "Sample - Not for sale" and "Rx Only." Storage instructions indicate to store at controlled room temperature and keep the container tightly closed and out of reach of children.*
FDA Label Image

Chemical Structure (Cyclobenz Str)

Chemical Structure (Cyclobenz Str)
Chemical structure diagram of Cyclobenzaprine Hydrochloride, showing its molecular framework with labelled chemical groups and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.